Becker News and Research

RSS

Circadian gene mutation increases drug-taking behaviors in mice

A mutation in the gene regulating circadian rhythms increases self-administration of cocaine in mice, University of Pittsburgh Schools of the Health Sciences researchers found in a paper published today in the Journal of Neuroscience.

2 Dec 2020

New research project to develop and test novel intervention for individuals with HIV/AIDS

Tulsa CARES is partnering with researchers at the Hudson College of Public Health at the University of Oklahoma Health Sciences Center and the OU-TU School of Community Medicine at the University of Oklahoma to develop and test a novel "food as medicine" intervention for individuals affected by HIV/AIDS.

2 Dec 2020

OU College of Medicine, US Department of Defense to address problematic sexual behavior of youth

When young people act out sexually in ways that are harmful to others or themselves, the stigma surrounding the issue can be paralyzing for everyone affected.

19 Nov 2020

OCD, anxiety and depressive symptoms worsen in young people during COVID-19

Many children and young people with obsessive thoughts and compulsions experience that their OCD, anxiety and depressive symptoms worsen during a crisis such as COVID-19.

9 Nov 2020

Deciphering heart-brain talk may help unlock the key to cardiovascular disease

The crosstalk of the heart and brain is continuous and deciphering those messages may help researchers unlock the key to cardiovascular disease, says Deeptankar DeMazumder, MD, PhD, assistant professor in the University of Cincinnati College of Medicine.

6 Nov 2020

Genetic mutation may accelerate heart function decline in DMD patients

A mutation in the gene that causes cystic fibrosis may accelerate heart function decline in those with Duchenne muscular dystrophy (DMD), a new study by UT Southwestern researchers suggests.

4 Nov 2020

Ultramicroscopy helps visualize tumor tissues in three dimensions

After cancer surgery, the crucial question is: Are there possibly cancer cells left behind that can continue to grow, or has the entire tumor actually been removed? To find out, the tumor is examined by pathologists.

28 Oct 2020

New method can detect high levels of COVID-19 antibodies

A more efficient and much faster method to assess high levels of neutralizing antibodies to COVID-19 could point the way to better understanding and treatment of the disease, according to new published findings by scientists from the Hackensack Meridian Center for Discovery and Innovation (CDI) and the University of Michigan (U-M).

23 Oct 2020

Patients with soft-tissue cancer show rapid and complete response to novel combination of immunotherapy

A patient with end-stage and rapidly progressing soft-tissue cancer whose tumor did not respond to standard treatment, had a "rapid and complete response" to a novel combination of immunotherapy, according to new research published by a team of scientists from John Theurer Cancer Center at Hackensack University Medical Center and the Georgetown Lombardi Comprehensive Cancer Center, both of whom are part of the Georgetown Lombardi Comprehensive Cancer Center Consortium.

16 Oct 2020

Deeper grief correlates with an overarching decline in quality of life, shows study

How will you cope with the death of your mother or spouse? Their death may disturb your concentration, causing accidents or lowering your productivity. Some bereaved cannot sleep, and others cannot get out of bed.

6 Oct 2020

UC researchers find potential treatment that could be applied to COVID-19

By examining preexisting research for other conditions, researchers at the University of Cincinnati have found a potential treatment that could be applied to COVID-19.

29 Sep 2020

Phase 2 clinical trial to examine the effects of razuprotafib on COVID-19 patients

Researchers at the University of Cincinnati and UC Health will host a Phase 2 clinical trial (NCT04511650) to examine the effects of a drug that targets blood vessel inflammation and injury in patients with COVID-19.

22 Sep 2020

Lack of antigen test reporting leaves country ‘blind to the pandemic’

More than 20 states either don't release or have incomplete data on the rapid antigen tests now considered key to containing the coronavirus, which has sickened more than 6 million Americans.

16 Sep 2020

Treatment with a cannabinoid prevented the development of colon cancers in mice

Inflammatory bowel diseases (IBD) such as Crohn's disease and ulcerative colitis are caused by unrestrained inflammation of the gastrointestinal tract.

15 Sep 2020

MSU engineers secure $3.4 million to develop diamond devices to detect Parkinson's

Engineers from Michigan State University have secured $3.4 million in grants to develop diamond implants that could let doctors diagnose and treat Parkinson's disease earlier.

12 Sep 2020

Drug used in rheumatoid arthritis and cancer treatment improves survival in critically ill COVID-19 patients

Researchers at Hackensack Meridian Health, New Jersey's largest and most comprehensive health network, have utilized its statewide observational database of more than 5,000 hospitalized COVID-19 patients to show that a drug normally used in rheumatoid arthritis and cancer treatments, tocilizumab, improves hospital survival in critically-ill patients admitted to the intensive care unit (ICU).

20 Aug 2020

Applying "temporal pressure" to the skin can help deliver more drugs

Scientists from Nanyang Technological University, Singapore (NTU Singapore) and the Agency for Science, Technology and Research (A*STAR) have showed that applying "temporal pressure" to the skin of mice can create a new way to deliver drugs.

4 Aug 2020

Research shows low risk for healthy travelers to acquire Candida auris

Researchers have shown that there is a low risk for healthy people to acquire Candida auris during travel. The research is presented at ASM Microbe Online, the annual meeting of the American Society for Microbiology.

24 Jul 2020

C-Path gets positive response from FDA for drug-induced skeletal muscle injury safety biomarkers

Critical Path Institute announced today that the Biomarker Qualification Program at the Center for Drug Evaluation and Research in the U.S. Food and Drug Administration issued a positive response to the Letter of Intent developed by C-Path's Predictive Safety Testing Consortium and Duchenne Regulatory Science Consortium, for a panel of four safety biomarkers of acute drug-induced skeletal muscle injury.

23 Jul 2020

Researchers isolate potent SARS-CoV-2 neutralizing antibodies

An important line of defense in the fight against the new coronavirus SARS-CoV-2 is the formation of neutralizing antibodies.

8 Jul 2020